Time | Session |
---|---|
17:00
18:00
|
Acid-base and Electrolyte Abnormalities in Kidney Disease
|
17:00
18:00
|
Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
|
17:00
18:00
|
Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
|
17:00
18:00
|
Chronic Kidney Disease Diagnosis, Classification and Progression 2
|
17:00
18:00
|
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
|
17:00
18:00
|
Clinical Glomerulonephritis 3
|
17:00
18:00
|
Covid-19 and CKD
|
17:00
18:00
|
Curriculum
|
17:00
18:00
|
Diabetic Kidney Disease, Drugs and Treatments 2
|
17:00
18:00
|
Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
|
17:00
18:00
|
Epidemiology, Outcomes and Health Services Research in Dialysis 2
|
17:00
18:00
|
Essential Hypertension and Renovascular Kidney Disease
|
17:00
18:00
|
Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
|
17:00
18:00
|
Haemodialysis, Haemodiafiltration and Vascular Access 2
|
17:00
18:00
|
Haemodialysis, Haemodiafiltration and Vascular Access 3
Jonathan Himmelfarb
Moderator
jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
|
17:00
18:00
|
Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
|
17:00
18:00
|
Kidney Transplantation and Transplant Immunology 3
|
17:00
18:00
|
Kidney Transplantation and Transplant Immunology 4
|
17:00
18:00
|
Late Breaking Clinical Trials
|
17:00
18:00
|
Nephrotic Syndrome
|
17:00
18:00
|
Other CKD 2
|
17:00
18:00
|
Other KF (Kidney Failure)
|
17:00
18:00
|
Peritoneal Dialysis 2
|
17:00
18:00
|
Peritoneal Dialysis 3
|
17:00
18:00
|
Training
|
17:00
18:00
|
Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
|
17:00
18:00
|
Urologic Disorders – Stones, Nephrocalcinosis
|
17:00
18:00
|
Vascular Biology and Endothelial Function
|